Medical News Today: Experimental drug targets prostate cancer's chief weakness



In prostate cancer, recurring tumors become aggressive and treatment-resistant. Why does this happen, and how can it be prevented? A new study weighs in.



Source link

This entry was posted on May 7, 2018, in News. Bookmark the permalink.